新活素治疗严重脓毒症合并心力衰竭中的脉搏指示持续心输出量监测

Monitoring of pulse indicator continuous cardiac output in patients with severe sepsis complicated with heart failure treated by recombinant human brain natriuretic peptide

  • 摘要: 目的 探讨脉搏指示持续心输出量监测(PICCO)技术在新活素治疗严重脓毒症合并心力衰竭患者中的应用效果。 方法 选取40例严重脓毒症合并心力衰竭患者作为研究对象,随机分为研究组和对照组,每组20例。对照组采用常规心力衰竭治疗方案,研究组在对照组基础上加用新活素治疗。用PICCO监测仪分别测定2组患者用药前和用药后24、48、72 h的心脏指数(CI)、每搏量指数(SVI)、全心舒张末期容量指数(GEDI)、血管外肺水指数(ELWI)、全身血管阻力指数(SVRI)、全心射血分数(GEF)和心功能指数(CFI), 连续测3次并取平均值,同步记录心率(HR)、平均动脉压(MAP)、中心静脉压(CVP)、收缩压(SBP)和舒张压(DBP)结果。 结果 用药后24、48、72 h, 研究组患者SBP水平均显著低于对照组(P<0.05), 但2组HR、CVP、MAP、DBP水平比较,差异无统计学意义(P>0.05)。用药后24、48、72 h, 研究组CFI、ELWI水平优于对照组,差异有统计学意义(P<0.05); 与用药前比较,研究组CI、SVI和GEF水平于用药后24 h即显著升高(P<0.05), 而对照组CI、SVI水平则于用药后72 h显著升高, GEF水平于用药后48 h显著升高(P<0.05); 用药后, 2组患者GEDI和SVRI水平均降低,但用药前后比较,差异无统计学意义(P>0.05)。 结论 新活素可有效改善严重脓毒症合并心力衰竭患者的心功能,而PICCO技术是监测血流动力学和血容量有效且实用的方法。

     

    Abstract: Objective To observe the application effect of pulse indicator continuous cardiac output(PICCO)for patients with severe sepsis complicated with acute heart failure treated by recombinant human brain natriuretic peptide. Methods A total of 40 patients with severe sepsis complicated with heart failures were selected as study objects, and were randomly divided into study group and control group, with 20 cases in each group. The control group was given anti-heart failure drugs, while the study group was additionally treated by recombinant human brain natriuretic peptide based on the control group. PICCO monitor was used to detect cardiac index(CI), stroke volume index(SVI), global end-diastolic volume index(GEDI), extracascular lung water index(ELWI), systemic vascular resistance index(SVRI), global ejection fraction( GEF), and cardiac function index(CFI)before drug use and at 24, 48 and 72 h after drug use in the two groups. Three continuous determination was performed, and average value was obtained. Heart rate(HR), mean arterial pressure(MAP), central venous pressure(CVP), systolic blood pressure(SBP), and diastolic blood pressure(DBP)were recorded at the same time. Results At 24, 48, 72 h after drug use, SBP in the study group was lower than that in the control group(P<0.05), but HR, CVP, MAP, DBP had no significant differences between the two groups(P>0.05). The levels of CFI and ELWI at 24, 48, 72 h after drug use were better than those in the control group(P<0.05). The levels of CI, SVI and CFI in the study group increased- significantly after 24 h of medication compared with medicine use before(P<0.05). The levels of CI and SVI were significantly increased at 72 h after medication, while the level of GEF was increased at 48 after medication in the contol group(P<0.05). After drug use, the levels of GEDI and SVRI were decreased after medication use, but no differences were found after medication use compared with medication use before(P>0.05). Conclusion Recombinant human brain natriuretic peptide can effectively improve cardiac function in heart failure patients with severe sepsis. PICCO technique is an effective and practical method for monitoring blood flow dynamics and blood volume.

     

/

返回文章
返回